{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:35Z","timestamp":1788872435336,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["TPM 61-037"],"award-info":[{"award-number":["TPM 61-037"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","award":["CI-51755N"],"award-info":[{"award-number":["CI-51755N"]}],"id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1378\/chest.12-1770","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T12:32:33Z","timestamp":1357216353000},"page":"1312-1320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Combination Antihypertensive Therapy Among Patients With COPD"],"prefix":"10.1016","volume":"143","author":[{"given":"Melissa A.","family":"Herrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Cecere","family":"Feemster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Crothers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Uman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris L.","family":"Bryson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1378\/chest.12-1770_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1513\/pats.200701-001FM","article-title":"The epidemiology and economics of chronic obstructive pulmonary disease","volume":"4","author":"Mannino","year":"2007","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"10.1378\/chest.12-1770_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjmed.2008.09.042","article-title":"Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD","volume":"122","author":"Barr","year":"2009","journal-title":"Am J Med"},{"issue":"1","key":"10.1378\/chest.12-1770_bib3","first-page":"e2","article-title":"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1378\/chest.12-1770_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1378\/chest.12-1770_bib5","first-page":"1901","article-title":"Preventing congestive heart failure","volume":"57","author":"Cohn","year":"1998","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1378\/chest.12-1770_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jash.2010.02.005","article-title":"Combination therapy in hypertension","volume":"4","author":"Gradman","year":"2010","journal-title":"J Am Soc Hypertens"},{"issue":"9227","key":"10.1378\/chest.12-1770_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","article-title":"Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"356","author":"Brown","year":"2000","journal-title":"Lancet"},{"issue":"9311","key":"10.1378\/chest.12-1770_bib8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"issue":"9153","key":"10.1378\/chest.12-1770_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"9227","key":"10.1378\/chest.12-1770_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study","volume":"356","author":"Hansson","year":"2000","journal-title":"Lancet"},{"issue":"18","key":"10.1378\/chest.12-1770_bib11","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","article-title":"Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial","volume":"292","author":"Nissen","year":"2004","journal-title":"JAMA"},{"issue":"23","key":"10.1378\/chest.12-1770_bib12","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","year":"2002","journal-title":"JAMA"},{"issue":"9386","key":"10.1378\/chest.12-1770_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.1378\/chest.12-1770_bib14","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.12-1770_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1472-6963-11-37","article-title":"The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease","volume":"11","author":"Cooke","year":"2011","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"10.1378\/chest.12-1770_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MLR.0b013e3180329368","article-title":"A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp)","volume":"45","author":"Bryson","year":"2007","journal-title":"Med Care"},{"issue":"11","key":"10.1378\/chest.12-1770_bib17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-149-11-200812020-00004","article-title":"Alcohol screening scores and medication nonadherence","volume":"149","author":"Bryson","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1378\/chest.12-1770_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archinte.160.2.197","article-title":"Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project","volume":"160","author":"Goff","year":"2000","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1378\/chest.12-1770_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1378\/chest.11-0024","article-title":"The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations","volume":"141","author":"Stein","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.12-1770_bib20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1378\/chest.11-2413","article-title":"Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study","volume":"142","author":"Almagro","year":"2012","journal-title":"Chest"},{"issue":"13","key":"10.1378\/chest.12-1770_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1378\/chest.12-1770_bib22","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"issue":"17","key":"10.1378\/chest.12-1770_bib23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.110.012575","article-title":"Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"124","author":"Piller","year":"2011","journal-title":"Circulation"},{"issue":"19","key":"10.1378\/chest.12-1770_bib24","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1378\/chest.12-1770_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.amjcard.2008.09.081","article-title":"Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes","volume":"103","author":"Olenchock","year":"2009","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1378\/chest.12-1770_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/pds.963","article-title":"Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?","volume":"13","author":"Wei","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9287","key":"10.1378\/chest.12-1770_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1378\/chest.12-1770_bib28","doi-asserted-by":"crossref","unstructured":"Proschan M, Ford CE, Cutler JA, et al. ALLHAT Collaborative Research Group. How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? Stat Med. In press. doi:10.1002\/sim.5580.","DOI":"10.1002\/sim.5580"},{"issue":"9","key":"10.1378\/chest.12-1770_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1751-7176.2009.00149.x","article-title":"Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?","volume":"11","author":"Grimm","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"8","key":"10.1378\/chest.12-1770_bib30","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00005650-198808000-00007","article-title":"A general method of compliance assessment using centralized pharmacy records. Description and validation","volume":"26","author":"Steiner","year":"1988","journal-title":"Med Care"},{"issue":"1","key":"10.1378\/chest.12-1770_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1378\/chest.12-1770_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3724\/SP.J.1263.2012.00005","article-title":"Prevalence of cardiovascular disease in subjects hospitalized due to chronic obstructive pulmonary disease in Beijing from 2000 to 2010","volume":"9","author":"Cui","year":"2012","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"10.1378\/chest.12-1770_bib33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2004.03.048","article-title":"Association between chronic heart failure and inhaled beta-2-adrenoceptor agonists","volume":"148","author":"Au","year":"2004","journal-title":"Am Heart J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213603293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213603293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:36:29Z","timestamp":1757918189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213603293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0012369213603293"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-1770","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination Antihypertensive Therapy Among Patients With COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-1770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}